The Incidence of Various Antiphospholipid Antibodies, Measured by Commercial-Based Laboratory, with Recurrent Spontenous Abortion and the Impact of Their Profiles on Reproductive Outcome with Active Anticoagulant Therapy
Table 2
Reproductive outcomes of the anticoagulant therapy according to various aPL profiles in RSA patients.
Pregnancy
aPL species and titer
Establisheda () total 81
Maintaineda () total 74
Aborteda () total 7
Success rate (%) 91.4
value (weakly versus strongly)
Species
Titer
LA
weakly
32
30
2
93.8
93.8
—
strongly
0
0
0
—
aβ2GPI
weakly
1
1
0
100
100
—
strongly
0
0
0
—
aCL-IgG
weakly
6
6
0
100*, **
100
—
strongly
8
8
0
100
-IgM
weakly
25
24
1
95.0
96.0
0.708
strongly
15
14
1
93.3
aPE-IgG
weakly
17
15
2
92.0
88.2
0.312
strongly
8
8
0
100
-IgM
weakly
12
11
1
94.1
91.7
0.506
strongly
5
5
0
100
aPS-IgG
weakly
6
5
1
90.0**
83.3
0.389
strongly
4
4
0
100
-IgM
weakly
28
24
4
88.1*
85.7
0.500
strongly
14
13
1
82.9
aSome patients had multiple positive aPLs. P value for *was 0.176 and for **was 0.227.